Multiple Myeloma Research Consortium Shares its Insights into Effective and Efficient Biospecimen Management
News Jun 18, 2007
LabVantage has announced a webcast featuring the Multiple Myeloma Research Consortium (MMRC). The MMRC shares its insights into the implementation of LabVantage’s Sapphire BioBanking Solution for the effective and efficient biospecimen management system to support myeloma research throughout MMRC's partner network.
In the world of research, accurate, compliant and efficient management of biospecimens is critical. These specimens serve as the basis for research and development of tomorrow's drugs and medical treatments.
The MMRC reviews the challenges of sample collection, storage, management, and reporting associated with its myeloma specimens. It also addresses the specific barriers to specimen management and data warehousing faced by the MMRC, including how to: span the life cycle of the specimen, address the needs of multiple end users, capture correlating clinical data, maintain flexibility, and provide global visibility.
This webcast and further information about LabVantage's Sapphire BioBanking Solution are available at http://www.labvantage.com/products/biobanking/index.html.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
Highly Potent Active Pharmaceutical Ingredients (HPAPI)
May 21 - May 22, 2018